A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Cardioprotective Effects of study drug in Patients Undergoing High-Risk Coronary Artery Bypass Graft (CABG) Surgery (MEND-CABG)

Sponsor: Medicure

Investigator: Todd Dewey, MD
Research Coordinator: Tina Worley, RN, BSN
                                 Tonya Goldston, RN, BSN, CCRC

Designated Site: Medical City Dallas


The objective of this study is to evaluate the safety and efficacy of study drug in the prevention of MI, stroke and death in patients undergoing CABG with cardiopulmonary bypass.